Bing

SEARCH HISTORY

Covidien plc ( COV) was a big mover last session with its shares surging over 20% on the day. The positive market sentiment was a result of medical technology giant Medtronic Inc. 's ( MDT) announcement of its plans to acquire Covidien in a deal worth $42 ...
NASDAQ · 6/17/2014
On Sunday, June 16th, medical device maker Medtronic (NYSE:MDT) announced its plans to buy Covidien (NYSE:COV) for $43 billion in debt and stock, the largest transaction in medical device history. Each Covidien share was valued at $93.22, paid by …
Seeking Alpha · 3/9/2015
Ireland-based Covidien's U.S. stock was up more than 2% ... Novarro wrote that he expects the buyout to close in late January or early February.
Investors Business Daily · ByAmy Reeves · 1/22/2015
More from Bing News
Medical device-maker Medtronic has agreed to acquire peer Covidien for $42.9 billion in cash and stock. The purchase values Covidien at $93.22 per Covidien share. Covidien closed at $72.02 on Friday. "We are excited to reach this agreement with Covidien ...
The Business Insider · BySam Ro · 6/16/2014
And that's apart from the holdings in Covidien stock the executives are expected to maintain (5 times base salary for Almeida and 3 times base salary for the other executives, according to the SEC filing). In the case of Almeida, who pulled down $11.2 ...
MassDevice · 6/17/2014
Terms of the deal would have Medtronic pay about $43 billion in cash and stock for Covidien, thereby creating a medical products giant with 87,000 employees in more than 150 countries. While the executive offices would move to Ireland for tax purposes ...
TwinCities Pioneer Press · ByChristopher Snowbeck · 7/27/2014
Covidien Plc (COV), a global provider of healthcare products, Monday announced the completion of the the separation of its Pharmaceuticals business. The new entity now held by Mallinckrodt plc will begin 'regular way' trading on the New York Stock
Realtime Business News · 7/1/2013
The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300) This is a FREE report from Insider Monkey.
INSIDER MONKEY · 4/9/2015
based on Medtronic's closing stock price of $75.59 per share on Jan 26, 2015. Under the terms of the transaction, each ordinary outstanding shareholder of Covidien as of the closing date will receive $35.19 in cash and 0.956 of an ordinary share of ...
ZACKS · 1/27/2015
Farallon Capital Management increased its position in Covidien plc (COV) during the third quarter. The stock accounted for 5.06% of the fund’s total portfolio—up from 2.86% of the fund’s 2Q14 portfolio. On June 15, 2014, the leading medical device ...
Market Realist · 12/18/2014